Clinical Trial

Effectiveness Evaluation of a Mobile Application for Rheumatoid Arthritis

Study acronym: RA-App
Completed
View on ClinicalTrials.gov →
Summary
The aim of this experimental study is to develop a mobile application for patients with rheumatoid arthritis based on evidence-based recommendations and to evaluate the effectiveness of the developed application. Research Questions 1. Is the mobile application developed for patients with rheumatoid arthritis effective in improving their quality of life? 2. Is the mobile application developed for patients with rheumatoid arthritis effective in reducing their disease activity? The researchers will enable the intervention group to use the mobile application in order to assess its effectiveness, while the control group will receive routine care throughout the study period. Participants in the intervention group will use the mobile application for 12 weeks. Changes in the parameters determined by the researchers will be examined before and after the usage period. Patients in the control group will be evaluated after the initial consultation and at the end of 12 weeks. At the conclusion of the study, the control group will also be provided access to the mobile application.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-07; most recent amendment 2026-04-08.
Status change: Not Yet Recruiting → Completed 2026-04-08
Trial Details
NCT Number NCT06873607
Lead Sponsor Kırıkkale University
Conditions Rheumatoid Arthritis, Mobile Application
Enrollment 90 participants
Start Date 2025-07-01
Primary Completion 2026-01-31 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-13